BeOne Medicines AG (ONC) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for BeOne Medicines AG, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 115.48x | -30.16x | -20.96x | -11.32x | -17.24x | -13.27x |
| P/B Ratio | 7.60x | 5.84x | 5.22x | 5.17x | 4.10x | 5.57x |
| P/S Ratio | 6.20x | 5.10x | 7.51x | 16.02x | 21.37x | 69.83x |
| Profitability | ||||||
| Gross Margin | 87.5% | 84.4% | 84.5% | 79.8% | 86.0% | 77.1% |
| Operating Margin | 8.4% | -14.9% | -49.1% | -126.4% | -122.3% | -536.7% |
| Net Margin | 5.4% | -16.9% | -35.9% | -141.5% | -123.9% | -526.1% |
| EBITDA Margin | 11.5% | -10.4% | -45.6% | -121.7% | -118.4% | -526.4% |
| Liquidity | ||||||
| Current Ratio | 3.41x | 1.80x | 2.32x | 3.55x | 4.76x | 4.61x |
| Quick Ratio | 3.08x | 1.58x | 2.09x | 3.35x | 4.61x | 4.53x |
| Leverage | ||||||
| Debt/Equity | 0.46x | 0.32x | 0.26x | 0.14x | 0.11x | 0.15x |
YoY = year-over-year change. Source: FMP..